Abivax (ABVX) Goodwill (2022 - 2026)

Abivax's Goodwill history runs 5 years deep, the most recent figure standing at $21.6 million for Q1 2026.

• In Q1 2026, Goodwill rose 11.3% year-over-year to $21.6 million; the TTM figure through Mar 2026 stood at $21.6 million (up 11.3% YoY), while the FY2025 annual figure was $21.4 million, up 8.93% from the prior year.
• Goodwill was $21.6 million for Q1 2026 at Abivax, up from $21.4 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $21.6 million in Q1 2026 to a low of $18.8 million in Q4 2022.
• Historically, Goodwill has averaged $20.3 million across 5 years, with a median of $19.8 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Goodwill fell 0.68% in 2024, then gained 11.3% in 2026.
• A 5-year view of Goodwill shows it stood at $18.8 million in 2022, then rose by 5.46% to $19.8 million in 2023, then dropped by 0.68% to $19.7 million in 2024, then rose by 8.93% to $21.4 million in 2025, then climbed by 0.58% to $21.6 million in 2026.
• The last three Goodwill figures came in at $21.6 million (Q1 2026), $21.4 million (Q4 2025), and $21.5 million (Q3 2025), per Business Quant data.